ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

PJC Piper Jaffray Companies

79.62
0.00 (0.00%)
16 Aug 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type
Piper Jaffray Companies NYSE:PJC NYSE Common Stock
  Price Change % Change Share Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 79.62 0 01:00:00

Caroline Stewart Joins Piper Jaffray as Senior Biotechnology Research Analyst

01/06/2006 5:26pm

PR Newswire (US)


Piper Jaffray Companies (NYSE:PJC)
Historical Stock Chart


From Aug 2019 to Aug 2024

Click Here for more Piper Jaffray Companies Charts.
NEW YORK, June 1 /PRNewswire-FirstCall/ -- Piper Jaffray & Co. is pleased to announce that Caroline Stewart has joined the firm as a vice president and senior health care research analyst covering biotechnology companies. Stewart will be located in the firm's New York office. Stewart joins the firm from Morgan Joseph & Co./IRG LLC, where she was a senior research analyst covering small- to mid-cap development-stage and early-product biotechnology companies. She has previously researched biotechnology companies at Leerink Swann & Co./MEDACORP, Salomon Smith Barney and Deutsche Banc Securities. "We are excited to have Caroline join our health care research team," said Joel Denney, head of Investment Research at Piper Jaffray. "Caroline has several years of experience covering biotechnology companies, and we look forward to having her expertise and knowledge on our health care team as we continue to grow our biotechnology coverage." Stewart received her master's of science degree in molecular and cell biology and chemistry from Brandeis University in Waltham, Mass., and her bachelor's degree in chemistry from Columbia University in New York. Piper Jaffray & Co. is the chief operating subsidiary of Piper Jaffray Companies (NYSE:PJC), a focused securities firm dedicated to delivering superior financial advice, investment products and transaction execution within selected sectors of the financial services marketplace. The company currently operates through two primary revenue-generating segments: Capital Markets and Private Client Services. The sale of the company's Private Client Services branch network, announced April 11, 2006, currently is pending. The company's Capital Markets business generates revenue through two groups, Corporate and Institutional Services and Public Finance Services. Through its chief operating subsidiary, Piper Jaffray & Co., the firm has served corporations, government and nonprofit entities, institutional investors and the financial advisory needs of private individuals since 1895. With headquarters in Minneapolis, Piper Jaffray has approximately 2,800 employees in 107 offices in 23 states across the country and in London. For more information about Piper Jaffray, visit us online at http://www.piperjaffray.com/ . Since 1895. Member SIPC and NYSE. DATASOURCE: Piper Jaffray & Co. CONTACT: Susan Beatty, Media Relations of Piper Jaffray & Co., +1-612 303-5680 Web site: http://www.piperjaffray.com/

Copyright

1 Year Piper Jaffray Companies Chart

1 Year Piper Jaffray Companies Chart

1 Month Piper Jaffray Companies Chart

1 Month Piper Jaffray Companies Chart

Your Recent History

Delayed Upgrade Clock